CanadaSpiriva 18 mcg capsule (tiotropium bromide monohydrate 18 mcg), DIN 02246793, Lot 405636 distributed by Boehringer Ingelheim Canada Ltd. in Canada is affected; check the lot number on your product to recognise if yours is included. The lot was recalled because it may not consistently provide the intended dose; verify if your product is affected, consult your healthcare provider before discontinuing use, contact the recalling firm with questions, and report any side effects or other safety complaints to Health Canada.
What's being recalled
Depth of recall: Wholesalers
Companies: Boehringer Ingelheim Canada Ltd., 5180 South Service Road,, Burlington ON, L7L 5H4 Canada.
How to identify it
Brand: Boehringer Ingelheim Canada Ltd.; Product Name: Spiriva 18mcg capsule; Market Authorization: DIN 02246793; Dosage Form: Capsule; Strength: Tiotropium bromide monohydrate 18mcg; Lot Number: 405636
The hazard
The affected lot may not consistently provide the intended dose of medication with each use.
What to do
Verify if your product is affected.
Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
Contact the recalling firm if you have any questions about the recall.
Report any health product related side effects to Health Canada.
Report any other health product safety complaints to Health Canada.
The official notice
This page is a summary of the notice published by Health Canada, collected from Health Canada, CFIA and Transport Canada. Check the original before you act on it.
Read the official notice (opens in a new tab)